2-氧代-PCE

2-氧代-PCE（2-Oxo-PCE），或N-ethyldeschloroketamine、eticyclidone、O-PCE，是一種芳基環己胺類解離麻醉劑，與去氯愷他命（英語：Deschloroketamine）和乙環利定關係密切，曾被製成策劃藥於網上銷售。^{[4][5][6][7][8][9][10][11]}

2-氧代-PCE

法律規範狀態
法律規範	加：Schedule I[1] 德：NpSG 英：Class B 於香港和瑞典非法[2][3]
識別資訊
IUPAC命名法 2-(ethylamino)-2-phenyl-cyclohexanone
CAS號	6740-82-5  Y 4551-92-2  Y
PubChem CID	132989542
ChemSpider	76590394
UNII	2TRF16U3MR hydrochloride: 6Q4N3KH3MG Y
化學資訊
化學式	C14H19NO
摩爾質量	217.31 g·mol−1
3D模型（JSmol（英語：JSmol））	交互式圖像
SMILES CCNC1(CCCCC1=O)C2=CC=CC=C2
InChI InChI=1S/C14H19NO/c1-2-15-14(11-7-6-10-13(14)16)12-8-4-3-5-9-12/h3-5,8-9,15H,2,6-7,10-11H2,1H3 Key:IDLSBAANXISGEI-UHFFFAOYSA-N

參考文獻

1. Controlled Drugs and Substances Act (S.C. 1996, c. 19) - SCHEDULE I. Government of Canada - Justice Laws Website. [15 July 2020]. （原始內容存檔於2023-06-04）.
2. Cheng WC, Dao KL. The Emergence of Deschloro-N-ethyl-ketamine, a Ketamine Analog, in Drug Seizures and Drug Driving Cases in Hong Kong. Journal of Analytical Toxicology. April 2020, 44 (8): 886–895. PMID 32364605. doi:10.1093/jat/bkaa038 .
3. Fjorton nya ämnen klassas som narkotika eller hälsofarlig vara. Folkhälsomyndigheten. 12 November 2018 [2023-10-01]. （原始內容存檔於2021-01-20） （瑞典語）.
4. deschloro-N-ethyl-Ketamine (hydrochloride) (CAS 4551-92-2). www.caymanchem.com. [2023-10-01]. （原始內容存檔於2023-07-09）.
5. Jason W, Brandt SD. 1,2-Diarylethylamine- and Ketamine-Based New Psychoactive Substances. Handbook of Experimental Pharmacology 252. Springer International Publishing. September 2018: 305–352. ISBN 978-3-030-10561-7. PMID 30196446. doi:10.1007/164_2018_148 –透過Springer Link.
6. Chong YK, Tang MH, Chan CL, Li YK, Ching CK, Mak TW. 2-oxo-PCE: ketamine analogue on the streets. Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi. December 2017, 23 (6): 665–6. PMID 29226843. doi:10.12809/hkmj177089 .
7. Tang MH, Chong YK, Chan CY, Ching CK, Lai CK, Li YK, Mak TW. Cluster of acute poisonings associated with an emerging ketamine analogue, 2-oxo-PCE. Forensic Science International. September 2018, 290: 238–243. PMID 30081327. S2CID 207558276. doi:10.1016/j.forsciint.2018.07.014.
8. Tang MH, Hung LY, Lai CK, Ching CK, Mak TW. 9-year review of new psychoactive substance use in Hong Kong: A clinical laboratory perspective. Hong Kong Journal of Emergency Medicine. September 2018, 26 (3): 179–185. ISSN 1024-9079. doi:10.1177/1024907918798553 .
9. Li C, Lai CK, Tang MH, Chan CC, Chong YK, Mak TW. Ketamine analogues multiplying in Hong Kong. Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi. April 2019, 25 (2): 169. PMID 30971512. doi:10.12809/hkmj197863 .
10. Theofel N, Möller P, Vejmelka E, Kastner K, Roscher S, Scholtis S, Tsokos M. A Fatal Case Involving N-Ethyldeschloroketamine (2-Oxo-PCE) and Venlafaxine. Journal of Analytical Toxicology. March 2019, 43 (2): e2–e6. PMID 30365028. doi:10.1093/jat/bky063.
11. Tamama K, Lynch MJ. Newly Emerging Drugs of Abuse. Substance Use Disorders. Handbook of Experimental Pharmacology 258. October 2019: 463–502. ISBN 978-3-030-33678-3. PMID 31595417. S2CID 203983418. doi:10.1007/164_2019_260.